The invention provides an isolated and purified nucleic acid sequence encoding a chimeric antigen receptor (CAR) directed against 8 cell Maturation Antigen (BCMA). The invention also provides for use of the chimeric antigen receptor in adoptive T cell therapies for B cell related conditions.